Conavi Medical Corp
XTSX:CNVI
Conavi Medical Corp
Research & Development
Conavi Medical Corp
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Conavi Medical Corp
XTSX:CNVI
|
Research & Development
-$15.3m
|
CAGR 3-Years
26%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
6%
|
|
|
Profound Medical Corp
TSX:PRN
|
Research & Development
-$21m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-19%
|
|
|
Nanalysis Scientific Corp
XTSX:NSCI
|
Research & Development
-CA$472k
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Theralase Technologies Inc
XTSX:TLT
|
Research & Development
-CA$2.6m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
2%
|
|
|
MedMira Inc
XTSX:MIR
|
Research & Development
-CA$965.6k
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
3%
|
|
|
O
|
Ondine Biomedical Inc
LSE:OBI
|
Research & Development
-CA$9.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Conavi Medical Corp
Glance View
Conavi Medical Corp is a CA-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Toronto, Ontario and currently employs 4 full-time employees. The company went IPO on 2008-04-28. Conavi Medical Corp., formerly Titan Medical Inc., is a Canada-based company. The firm is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary intervention (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.
See Also
What is Conavi Medical Corp's Research & Development?
Research & Development
-15.3m
USD
Based on the financial report for Sep 30, 2025, Conavi Medical Corp's Research & Development amounts to -15.3m USD.
What is Conavi Medical Corp's Research & Development growth rate?
Research & Development CAGR 10Y
6%
The average annual Research & Development growth rates for Conavi Medical Corp have been 26% over the past three years , -28% over the past five years , and 6% over the past ten years .